Condition
Fertility Risk
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05443698Not ApplicableCompletedPrimary
SELF-GYN1 (Sonograms Enable Looking Forward- Get Your iNformation 1 Trial)
NCT05509322Not ApplicableWithdrawnPrimary
Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial
NCT04784325Not ApplicableCompletedPrimary
Anti-Mullerian Hormone - At My Home
NCT04687189Not ApplicableCompletedPrimary
Sonograms Enable Looking Forward - Home Examinations Led by Providers Validation Study
Showing all 4 trials